Acute Unilateral Central Serous Chorioretinopathy after Immunization with Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Literature Review.
Semin Ophthalmol
; 37(6): 690-698, 2022 Aug.
Article
in English
| MEDLINE | ID: covidwho-1878616
ABSTRACT
INTRODUCTION:
A 43-year-old Caucasian male presented to our ophthalmology clinic with blurry vision and metamorphopsia in his right eye, 24 hours after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine.METHODS:
Clinical examination and imaging tests were consistent with acute unilateral central serous chorioretinopathy (CSCR) that completely resolved after 2 months without any treatment. He had no significant ophthalmic or medical history. He also lacked the classical risk factors for CSCR such as recent psychosocial stressors, Type-A personality traits, history of exogenous steroid use, connective tissue disorders and obstructive sleep apnea.RESULTS:
This appears to be only the second reported case of CSCR, temporally associated with a recombinant COVID-19 mRNA vaccine. We also present a summary of published reports demonstrating intraocular complications associated with the novel recombinant COVID-19 mRNA vaccines.CONCLUSION:
Findings in this report should not deter COVID-19 vaccinations given the rarity of aforementioned ocular complications and the greater benefit of protection from COVID-19 infection. Medical practitioners, however, should remain mindful of potential ocular complications, given the greater likelihood of occurrence with increasing vaccination booster rates.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Central Serous Chorioretinopathy
/
COVID-19
/
BNT162 Vaccine
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
/
Reviews
Topics:
Vaccines
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Semin Ophthalmol
Journal subject:
Ophthalmology
Year:
2022
Document Type:
Article
Affiliation country:
08820538.2022.2082255
Similar
MEDLINE
...
LILACS
LIS